Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up

Abstract Although both angiotensin receptor blockers (ARBs) and dihydropyridine calcium channel blockers (CCBs) are all suitable for the initiation of antihypertensive treatment, studies investigating efficacy and safety between ARBs and CCBs are limited, and there is no previous study comparing the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Han Saem Jeong, Hong‐Seok Lim, Hun-Jun Park, Wang-Soo Lee, Jin-Oh Choi, Hui Seung Lee, Sang-Ho Jo, Soon Jun Hong
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/496695593ae64872a6cbb06e900c011d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares